PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



ESMO Preceptorship on Lung Cancer Manchester 2020 Programme.ocr .pdf


Original filename: ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr.pdf
Title: ESMO Preceptorship on Lunga Cancer Manchester 2020 Programme
Author: European Society for Medical Oncology

This PDF 1.5 document has been generated by Microsoft® Word for Office 365 / ABBYY FineReader 12, and has been sent on pdf-archive.com on 17/01/2020 at 06:56, from IP address 92.253.x.x. The current document download page has been viewed 63 times.
File size: 236 KB (3 pages).
Privacy: public file




Download original PDF file









Document preview


ESMO-THE CHRISTIE
PRECEPTORSHIP PROGRAMME

LUNG CANCER
Multidisciplinary management, standards of care and future perspectives
Manchester, United Kingdom
11-13 March 2020
CO-CHAIRS:
Fiona Blackhall, United Kingdom
Enriqueta Felip, Spain
Raffaele Califano, United Kingdom

LEARNING OBJECTIVES
To
To
To
To
To
To
To
To

learn about the evidence-base for lung cancer screening and novel diagnostic modalities
learn about the management of early stage NSCLC and use of adjuvant treatments
understand the role of m ulti-m odality treatment in locally advanced NSCLC and limited stage SCLC
learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
understand the role of im m une-checkpoint blockade for lung cancer and to learn about novel im munotherapies
learn about treatment of NSCLC with oligom etastatic disease
learn about the systemic treatment of mesothelioma and SCLC
learn about the role of supportive and palliative care for thoracic malignancies

Wednesday, 11 March 2020
08:15-09:15
60’

Registration

09:15-10:55
100

SESSION 1
Screening and diagnostics for lung cancer

40’

Lung cancer screening

Chairs:
Enriqueta Felip, ES
Raffaele Califano, UK
Haval Balata, UK

30’

EBUS TBNA in diagnosis/staging of lung cancer

Richard Booton, UK

30’

Role of pathologist in diagnosis and mutation analysis of lung
cancer

Keith M. Kerr, UK



Coffee break

11:20-12:20
60’

SESSION 1 - cont.
Screening and diagnostics for lung cancer

30’

PET/CT in staging of lung cancer

30’

Medical thoracoscopy in the management of thoracic
malignancies

12:20-13:40

Chairs:
Fiona Blackhall, UK
Raffaele Califano, UK
Rohit Kochhar, UK

Lunch

30’

Surgery for early stage NSCLC

Chairs:
Giulia Veronesi, IT
Cecile Le Pechoux, FR
Giulia Veronesi, IT

30’

Stereotactic ablative RT for early stage NSCLC

Suresh Senan, NL

SESSION 2
Radical treatment of early stage NSCLC

14:40-15:00

Coffee break

30’

Adjuvant radiotherapy for completely resected early stage
NSCLC

Cecile Le Pechoux, FR

30’

Adjuvant chemotherapy for resected early stage NSCLC

Paul Taylor, UK

Close of day 1

Chairs:
Fiona Blackball, UK
Raffaele Califano, UK

16:00-16:10
10


Thursday, 12 March 2020

30’

1st line chemotherapy for advanced NSCLC

Chairs:
Fiona Blackball, UK
Martin Reck, DE
David Planchard, FR

30’

1st line Im m une-checkpoint blockade for NSCLC

Luis Paz-Ares, ES

30’

2nd line treatment for advanced NSCLC

M artin Reck, DE

09:05-10:35
90’

10:35-12:55
120


SESSION 3 - cont.
Advanced NSCLC

SESSION 3 - cont.
Advanced NSCLC
Treatment of EGFR mutant advanced NSCLC

Chairs:
Fiona Blackball, UK
Yvonne Summers, UK
Raffaele Califano, UK

Coffee break
Treatment of ALK/R0S1 positive advanced NSCLC

Fiona Blackhall, UK

Maintenance treatment for advanced NSCLC

Yvonne Summers, UK

Beyond A LK/R 0S 1 and EGFR: Novel m olecularly driven
targeted therapies in NSCLC

Simon Ekman, SE

Lunch

30’

Systemic treatment of mesothelioma

Chairs:
Enriqueta Felip, ES
Paul Baas, NL
Paul Baas, NL

30’

Treatment of oligom etastatic NSCLC

Anne-M arie C. Dingemans, NL

14:00-15:00
60’

SESSION 4
Palliative treatment of lung cancer and mesothelioma

Coffee break

15:30-16:30
60’

SESSION 4 -co n t.
Palliative treatment of lung cancer and mesothelioma

Chairs:
Raffaele Califano, UK
Tora S. Solheim , NO
Catherine McBain, UK

30’

Radical treatment of brain metastases: The importance of a
neuro-oncology m ulti-disciplinary approach

30’

Supportive and palliative care in lung cancer

Karin Jordan, DE

16:30-16:35
5’

Close of day 2

Chairs:
Fiona Blackball, UK
Raffaele Califano, UK

19:00

Welcome drink

19:30

Dinner

Friday, 13 March 2020

30’

Treatment of locally advanced NSCLC in the elderly

Chairs:
Fiona Blackball, UK
Paul E. V an S ch il, BE
David W oolf, UK

30’

Combined m odality treatment for NSCLC with N2 disease

Clara Chan, UK

30’

Role of surgery for N2 disease

Paul E. Van Schil, BE

09:10-10:40
90’

SESSION 5
Locally advanced NSCLC

10:40-11:00

Coffee break

11:00-12:00
60’

SESSION 5 - cont.
Locally advanced NSCLC

60’

Participants clinical case discussion (3x20’)

Chairs:
Corinne Faivre-Finn, UK
Paul E. V an S ch il, BE
Faculty

Each 20 min slot for clinical case discussion includes 10’ case presentation and 10’ Q&A / interactive panel discussion

12:00-13:00

Lunch

13:00-15:00
120

SESSION 6
SCLC



Treatment of limited stage SCLC

Chairs:
Corinne Faivre-Finn, UK
Enriqueta Felip, ES
Corinne Faivre-Finn, UK

Chemotherapy for extensive stage SCLC

M artin Friih, CH

Immune checkpoint blockade for SCLC

Pilar Garrido Lopez, ES

Targeted agents in SCLC

Enriqueta Felip, ES

Coffee break
15:15-16:15
60’

SESSION 6 - cont.
SCLC

Chairs:
Enriqueta Felip, ES
Raffaele Califano, UK
Neil Bayman, UK

30’

Prophylactic cranial irradiation and role of thoracic RT for
extensive stage SCLC

30’

Cellular immunotherapy

Fiona Thistlethwaite, UK

Conclusion and farewell

Raffaele Califano, UK

16:15-16:20
5’


ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr.pdf - page 1/3
ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr.pdf - page 2/3
ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr.pdf - page 3/3

Related documents


er1085
er1107
er1235
stomach cancer treatment surgery
dr pradeep jain best gi cancer surgeon in delhi
osteosarcoma clinical trials


Related keywords